Illumina Announces Favorable Outcome of its Patent Litigation Against Helicos BioSciences Corporation
16:05 EDT 29 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Illumina, Inc. (NASDAQ: ILMN) announced today that District Judge Sue L.
Robinson of the U.S. District Court for the District of Delaware granted
Illumina’s motion for summary judgment of invalidity of U.S. Patent No.
7,593,10...
Other Sources for this Article
Illumina, Inc.
Investors:
Scott Dawson,
858-882-6665
sdawson@illumina.com
or
Media:
Jennifer
Temple, 858-882-6822
pr@illumina.com
More From BioPortfolio on "Illumina Announces Favorable Outcome of its Patent Litigation Against Helicos BioSciences Corporation"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
